Earnings FeedTerminal

⌘K

Home/Insiders/Sweeny Nicole

SN

SEC Insider//CIK 0001827505

Sweeny Nicole

CIK 00018275051 companyFRAMINGHAM, MA

Transactions

10

Companies

1

Filings

1

CIK

0001827505

Recent Transactions

10 trades

Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−3,813→ 39,728 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−3,813→ 39,728 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-22+5,000→ 43,541 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-22+5,000→ 43,541 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-22−5,000→ 50,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-22−5,000→ 50,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+6,250→ 38,541 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−6,250→ 81,250 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+6,250→ 38,541 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−6,250→ 81,250 total

Companies

1

KalVista Pharmaceuticals, Inc.
Chief Commercial Officer
$KALV

Recent Filings

1

4
Sweeny Nicole
Dec 4, 2025

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov